Oncologists Cheer Melanoma Data

What happened: Leaked data from Moderna and Merck's melanoma vaccine trial drew praise from oncologists while Wall Street sold off the stocks, ahead of the planned presentation at the European Society for Medical Oncology meeting in Madrid. Why it matters: The reaction split doctors and investors, an unusual divergence for pivotal drug study results that are normally read the same way by clinicians, patients, and the market. Market: -1.3% today ($145.27), +37.5% YTD, 0.9x vol — as of 21:46 UTC

Leaked data from Moderna and Merck's melanoma vaccine trial drew praise from oncologists while Wall Street sold off the stocks, ahead of the planned presentation at the European Society for Medical Oncology meeting in Madrid.

The reaction split doctors and investors, an unusual divergence for pivotal drug study results that are normally read the same way by clinicians, patients, and the market. Market: -1.3% today ($145.27), +37.5% YTD, 0.9x vol — as of 21:46 UTC